Abstract

The present invention represents an in vitro implementable method and related kit for assessing the response to immune tolerance restoration therapy by evaluating the expression of specific microRNAs (miRNAs) as biomarkers of residual beta-cell function.

Research Institution

Università degli Studi di Siena

Numero di pubblicazione

GB201805329A

TRL

3

Technologies, Systems, Applications

Medical devices development, New drugs development